This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascularintervention and accelerates its shift into higher-growth markets. Cardiovascularintervention is one of the fastest-growing global medtech markets, with significant unmet patient need.
This transaction further extends Johnson & Johnson MedTech’s leadership in cardiovascularintervention. We are excited to begin collaborating directly with the Shockwave team and look forward to a bright future together.”
EuroPCR is the annual official congress of the European Association of Percutaneous CardiovascularInterventions (EACPI). EuroPCR 2024 was held 14-17 May in Paris, France. In this episode Dr. Chadi Alraies discusses the top 10 sessions from EuroPCR 2024.
Circulation: CardiovascularInterventions, Ahead of Print. Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may be appealing to many.
While medical therapy for right-sided heart failure is limited, treatment options for tricuspid regurgitation include surgery and, based on recent developments, several transcatheter interventions.
Publication date: Available online 20 April 2024 Source: The American Journal of Cardiology Author(s): Carlo Mannina, Annapoorna Kini, Andreina Carbone, Eric Neibart, Eduardo Bossone, Francesca Romana Prandi, Rami Tadros, Giovanni Esposito, Raimund Erbel, Samin K Sharma, Stamatios Lerakis
Over the past decade, the cardiac intensive care unit has continued to transform with an aging population, increased clinical acuity, burgeoning cardiac and noncardiac comorbidities, technologic advances in cardiovascularinterventions, and increased use of temporary mechanical circulatory support devices.
24 in Atlanta, GA, and was published online on March 25 in JACC, JACC: Basic to Translational Science, JACC: Case Reports, JACC: Heart Failure, JACC: CardiovascularInterventions and JACC: Advances. The following science will be presented at ACC.24
A State-of-the-Art review published in JACC: CardiovascularInterventions covers the epidemiology, clinical implications, risk factors and preventive strategies for new-onset conduction disturbances (CDs) and the need for permanent pacemaker implantation (PPI) after TAVR, which the authors note are a limitation of this therapy.
Additionally, the study was recently published online in JACC: CardiovascularInterventions. The ePTFE fluoropolymer component in the CLAAS device appears to be less thrombogenic which may reduce DRT; still, more studies are required to further validate these initial results."
There has been considerable progress in the prevention and treatment of cardiovascular disease, reducing the population burden of cardiovascular morbidity and mortality. Hypertension, Ahead of Print.
Despite decreasing rates of permanent pacemaker implantation (PPI) after TAVR, substantial site-level variation persists, suggesting the need for quality improvement initiatives like replicating best practices from high-performing sites and increased guideline-based education, according to a recent study published in JACC: CardiovascularInterventions. (..)
Circulation: CardiovascularInterventions, Ahead of Print. BACKGROUND:Transcatheter edge-to-edge mitral valve (MV) repair (TEER) is an effective treatment for patients with primary mitral regurgitation at prohibitive risk for surgical MV repair (MVr).
Circulation: CardiovascularInterventions, Ahead of Print. BACKGROUND:Prior clinical trials have demonstrated the efficacy of ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk pulmonary embolism (PE) using reduced thrombolytic doses and shorter infusion durations.
These key takeaways from the research letter on IVL-facilitated valvuloplasty for severely calcified mitral valve stenosis are published in the Journal of the American College of Cardiology (JACC) CardiovascularInterventions. an interventional cardiologist and structural heart disease expert at Henry Ford Health.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content